PV pharm branch, vendor, cage 0U9U0
Ended Awarded Last action
- Contract number
- SPE2D826F08G5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $309,830
Award facts
- Contract value 100% obligated
- $309,830.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $309,830.44 and awarded January 12, 2026, was issued to Amerisourcebergen Drug Corp (a subsidiary of parent company Cencora, Inc.) by the Defense Logistics Agency's Medical Supply Chain division. The contract carries a firm fixed price and is not set-aside, indicating it was awarded through open competition. Performance will be completed at the awardee's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of January 13, 2026. This delivery order represents one of multiple task orders executed under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which is valued at $999,999,999.00 and extends through December 2026.
The Indefinite Delivery Contract serves as a comprehensive global pharmaceutical support vehicle enabling Amerisourcebergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The underlying contract encompasses specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. As a major pharmaceutical distributor and critical federal medical procurement vendor, Amerisourcebergen's contract portfolio demonstrates its capability to fulfill requirements for military treatment facilities, veterans' healthcare programs, and other government healthcare systems. The Defense Logistics Agency is planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple awards designated for separate regions, which may affect future competitive positioning for pharmaceutical supply contracts.
Quick answers
Who was awarded contract SPE2D826F08G5?
SPE2D826F08G5 was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on January 12, 2026.
How much is contract SPE2D826F08G5 worth?
The government has obligated $309,830 on SPE2D826F08G5.
Is contract SPE2D826F08G5 an order under another contract?
Yes. SPE2D826F08G5 is a delivery order under SPE2DX22D0069, an indefinite delivery contract.
Was contract SPE2D826F08G5 competed?
The extent of competition for SPE2D826F08G5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award